Previous close | 30.61 |
Open | 30.56 |
Bid | 30.51 x 100 |
Ask | 30.73 x 100 |
Day's range | 30.23 - 30.92 |
52-week range | 25.33 - 42.63 |
Volume | |
Avg. volume | 646,527 |
Market cap | 1.425B |
Beta (5Y monthly) | 0.77 |
PE ratio (TTM) | 20.28 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Investors in Pacira BioSciences, Inc. ( NASDAQ:PCRX ) had a good week, as its shares rose 9.3% to close at US$29.86...
Pacira (PCRX) reports first-quarter 2024 results, wherein earnings miss but revenues beat estimates, driven by Exparel sales.
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2024 Earnings Call Transcript May 7, 2024 Pacira BioSciences, Inc. misses on earnings expectations. Reported EPS is $0.62 EPS, expectations were $0.64. PCRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing […]